Turning Point Therapeutics
Repotrectinib, a next-generation ROS1/TRK inhibitor small molecule therapeutic
- Sector
- Biotech
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 19
- 21 pending · first 2020
- Rank in peer group#89 of 1449
Capital timeline
No federal awards or Form D filings are on record for this company.
Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.
Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards
Founder? Add funding contextStanding among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#89 · top 6%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 19 granted of 40- PendingCrystalline Forms Of A Macrocyclic CompoundUSPTOApplication 19181635
- GrantedMacrocyclic Compounds And Uses ThereofUSPTOUS 12,606,571
- PendingChiral Diaryl Macrocycles And Uses ThereofUSPTOApplication 19190116
Show all 40 patent records
- Crystalline Forms Of A Macrocyclic CompoundJun 11, 2026 · Application 19181635Pending
- Macrocyclic Compounds And Uses ThereofApr 21, 2026 · US 12,606,571Granted
- Chiral Diaryl Macrocycles And Uses ThereofDec 11, 2025 · Application 19190116Pending
- Diaryl Macrocycles As Modulators Of Protein KinasesOct 14, 2025 · US RE50,634Granted
- Diaryl Macrocycles As Modulators Of Protein KinasesSep 2, 2025 · US 12,404,281Granted
- Therapeutic Uses Of Macrocyclic CompoundsAug 21, 2025 · Application 17905503Pending
- Diaryl Macrocycle PolymorphJul 10, 2025 · Application 18957501Pending
- Chiral Diaryl Macrocycles And Uses ThereofMay 27, 2025 · US 12,310,968Granted
- Diaryl Macrocycle PolymorphJan 7, 2025 · US 12,187,739Granted
- Synthesis Of Macroyclic CompoundsJan 2, 2025 · Application 18698692Pending
- Macrocyclic Compounds And Uses ThereofMay 14, 2024 · US 11,981,684Granted
- Combination Therapy Involving Diaryl Macrocyclic CompoundsFeb 1, 2024 · Application 18138644Pending
- Combination Therapy Involving Diaryl Macrocyclic CompoundsDec 14, 2023 · Application 18139859Pending
- Macrocycles For Use In Treating DiseaseOct 12, 2023 · Application 18123080Pending
- Combination Therapy Involving Diaryl Macrocyclic CompoundsJun 6, 2023 · US 11,666,574Granted
- Combination Therapy Involving Diaryl Macrocyclic CompoundsMay 23, 2023 · US 11,654,145Granted
- Macrocycles For Use In Treating DiseaseApr 25, 2023 · US 11,634,433Granted
- Polymorphs Of A Macrocyclic Kinase InhibitorDec 29, 2022 · Application 17618060Pending
- Macrocyclic Compounds For Treating DiseaseSep 29, 2022 · Application 17670665Pending
- Chiral Diaryl Macrocycles And Uses ThereofSep 27, 2022 · US 11,452,725Granted
- Diaryl Macrocycles As Modulators Of Protein KinasesApr 14, 2022 · Application 17485942Pending
- Combination Therapy Involving Diaryl Macrocyclic CompoundsApr 5, 2022 · US 11,291,667Granted
- Macrocyclic Compounds For Treating DiseaseMar 29, 2022 · US 11,286,265Granted
- Macrocyclic Compounds And Uses ThereofMar 29, 2022 · US 11,286,264Granted
- Macrocyclic Compounds And Uses ThereofOct 26, 2021 · US 11,155,563Granted
- Macrocycles For Use In Treating DiseaseOct 12, 2021 · US 11,142,533Granted
- Chiral Diaryl Macrocycles As Modulators Of Protein KinasesMay 18, 2021 · US 11,008,337Granted
- Diaryl Macrocycle PolymorphApr 1, 2021 · Application 17071569Pending
- Macrocyclic Kinase Inhibitors And Their UseMar 25, 2021 · Application 16772014Pending
- Macrocyclic Compounds For Treating DiseaseAug 18, 2020 · US 10,745,416Granted
- Diaryl Macrocycles As Modulators Of Protein KinasesJul 9, 2020 · Application 16797866Pending
- Macrocycle Kinase InhibitorsJun 23, 2020 · US 10,689,400Granted
- Diaryl Macrocycles As Modulators Of Protein KinasesApr 14, 2020 · US 10,618,912Granted
- Combination Therapy Involving Diaryl Macrocyclic CompoundsApplication PCTUS2020062390Pending
- Polymorphs Of A Macrocyclic Kinase InhibitorApplication 63036102Pending
- Combination Therapy Involving Diaryl Macrocyclic CompoundsApplication PCTUS2020062374Pending
- Macrocycles For Use In Treating DiseaseApplication 63015937Pending
- Combination Therapy Involving Diaryl Macrocyclic CompoundsApplication 63005681Pending
- Combination Therapy Involving Diaryl Macrocyclic CompoundsApplication 62992573Pending
- Therapeutic Uses Of Macrocyclic Compounds PpaApplication 62984159Pending
Related companies, and why
- VONA THERAPEUTICS LLCSimilar federal contract value in Biotech · null in contracts
- ASTERO ERADO INCSimilar federal contract value in Biotech · null in contracts
- CONIFER POINT PHARMACEUTICALS, LLCSimilar federal contract value in Biotech · null in contracts
- Stylus MedicineSimilar federal contract value in Biotech · null in contracts
- HYKU BIOSCIENCES INC.Similar federal contract value in Biotech · null in contracts
- HUMACYTE, INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .